Katherine Hanaway, MD
Obstetrics & Gynecology · Cambridge, MANPI 1457375727
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,660 of the $7,916 with a category attached, or 71.5%. Boston Scientific accounts for 78.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $3,753 and has fallen 63.1% since, to $1,383 in 2025. Among obstetrics & gynecology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $219.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Coloplast$613
- Medtronic$478
- Axonics, Inc.$287
- Caldera Medical, Inc$185
- AbbVie$52
- plus $99 from 3 others
What the payments were for
- Speaking & faculty fees$5,66072%
- Food & beverage$2,19928%
- Education$571%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 11 | $6,201 |
| Coloplast | 7 | $613 |
| Medtronic(2 entities) | 8 | $478 |
| Axonics, Inc. | 2 | $287 |
| Caldera Medical, Inc | 1 | $185 |
| AbbVie | 2 | $52 |
| Astellas Pharma US Inc | 2 | $39 |
| Therapeuticsmd, Inc. | 2 | $35 |
| Gynesonics, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,916 in reported general payments places this provider in the 95th percentile of 910 obstetrics & gynecology providers in Massachusetts.
See all obstetrics & gynecology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 288 | $197,094 |
| MyrbetriqMirabegron | 242 | $195,057 |
| Mirabegron ErMirabegron | 108 | $57,718 |
| Diazepam | 17 | $26,704 |
| Estradiol | 279 | $19,297 |
| EstringEstradiol | 20 | $10,287 |
| YuvafemEstradiol | 38 | $6,829 |
| Cephalexin | 100 | $1,137 |
| NitrofurantoinNitrofurantoin Macrocrystal | 36 | $859 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 87 | $746 |
| Methenamine Hippurate | 13 | $498 |
| Trospium Chloride | 19 | $409 |
| CefuroximeCefuroxime Axetil | 48 | $351 |
| Betamethasone Valerate | 11 | $260 |
| Doxycycline Monohydrate | 17 | $88 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $39 | $195,057242 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 910 obstetrics & gynecology providers in Massachusetts.
Other obstetrics & gynecology in Cambridge
- Emily von BargenCambridge$12K
- Brigid MumfordCambridge$10K
- Soheil Amin HanjaniBrockton$386K
- Joelle LiemanBrighton$215K
- Elizabeth OnyemelukweBoston$135K
- James GreenbergBoston$119K
- Stephanie AlimenaBoston$75K
- Denis VaughanBoston$38K
- Lara KingstonPlymouth$37K
- Erica RobinsonWorcester$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.